Authors:
Oficialdegui, AM
Martinez, J
Perez, S
Heras, B
Irurzun, M
Palop, JA
Tordera, R
Lasheras, B
del Rio, J
Monge, A
Citation: Am. Oficialdegui et al., Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin-1-yl]-1-arylpropane derivatives as potential antidepressants with a dual modeof action: serotonin reuptake inhibition and 5-HT1A receptor antagonism, FARMACO, 55(5), 2000, pp. 345-353